Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesCephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
Cephalon, 02/03/09
Cephalon, Inc. (Nasdaq: CEPH) announced that the company will exercise its option to license worldwide rights to Lupuzor(TM), an investigational medication for the treatment of Systemic Lupus Erythematosus, based on the promising interim results of the ImmuPharma Phase IIb study. Cephalon will assume all expenses for Phase III studies, regulatory filings and subsequent commercialization of the product.
Today in Licensure/Accreditation...keeping you current
Receive free subspecialty "5-minute updates" via email
EDI Accrediting Firm Updates Criteria
HealthDataManagement, 12/09/09
Consumer Demand for H1N1 Information Highlights Importance of Accreditation for Health Call Centers
URAC News Releases, 12/07/09
The Joint Commission’s Hospital Accreditation Recognized by CMS
Joint Commission news, 12/03/09
Article Search
Sponsor